PDCD1 and Miyoshi myopathy: A major role in the development of the immunosuppressive state in MM patients has been attributed to an increased expression of immune checkpoint molecules that negatively regulate T-cell function, such as PDCD1, CTLA4, BTLA and T-cell immunoglobulin and ITIM domains (TIGIT) on T cells (17–19).